Through
4/26
A round-up of Penn mentions in local, national, and international media.
Penn In the News
Itay Goldstein of the Wharton School says stock market prices still reflect the expectation that the Federal Reserve will cut rates later this year, even with the recent selloff.
Penn In the News
In a Q&A, Cait Lamberton of the Wharton School discusses the changing winds of corporate activism and the dilemma business leaders find themselves in with abortion.
Penn In the News
A 2020 study from the Perelman School of Medicine found that a blood test to screen for certain biomarkers associated with pancreatic cancer was 92% accurate in its ability to detect disease.
Penn In the News
Kathleen Hall Jamieson of the Annenberg Public Policy Center says that the sense of urgency around vaccination has faded as attention on respiratory viruses wanes.
Penn In the News
Gad Allon of the Wharton School says that Boeing’s first step to regaining trust should be firing its entire C suite.
Penn In the News
Holly Fernandez Lynch of the Perelman School of Medicine says that the lack of good treatment options for ALS has led to an insatiable desire to develop something that is going to modify the course of this disease.
Penn In the News
Tobias Barrington Wolff of Penn Carey Law says that appeals against punitive state bans concerning transgender rights make a strong case for Supreme Court intervention.
Penn In the News
Michael Mann of the School of Arts & Sciences says that the Doomsday Clock, while an imperfect metaphor, remains an important rhetorical device to remind people of the tenuousness of their current existence.
Penn In the News
Michael Mann of the School of Arts & Sciences says the climate change threat isn’t physics, it’s politics.
Penn In the News
Researchers at the School of Engineering and Applied Science led by Marc Miskin have built folding microrobots that could potentially go into human bodies to reconnect damaged nerve endings.